These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37506821)

  • 21. A Correlation Between Monocyte to Lymphocyte Ratio and Long-Term Prognosis in Patients With Coronary Artery Disease After PCI.
    Song FH; Zheng YY; Tang JN; Wang W; Guo QQ; Zhang JC; Bai Y; Wang K; Cheng MD; Jiang LZ; Zheng RJ; Fan L; Liu ZY; Dai XY; Zhang ZL; Yue XT; Zhang JY
    Clin Appl Thromb Hemost; 2021; 27():1076029621999717. PubMed ID: 33749340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
    Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
    Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.
    Li Y; Hou X; Liu T; Xu S; Huang Z; Xu X; Dong R
    Front Cardiovasc Med; 2022; 9():802181. PubMed ID: 35433853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte-to-albumin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention.
    Zhang ZL; Guo QQ; Tang JN; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Dai XY; Zheng RJ; Zheng YY; Zhang JY
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34137842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The age, NT-proBNP, and Ejection Fraction Score as a Novel Predictor of Clinical Outcomes in CAD Patients After PCI.
    Fan L; Zhang ZL; Tang JN; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Yue XT; Bai Y; Dai XY; Zheng RJ; Zheng YY; Zhang JY
    Clin Appl Thromb Hemost; 2022; 28():10760296221113345. PubMed ID: 35903893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study.
    Pan Y; Zhang J; Wu TT; Hou XG; Yang Y; Ma X; Ma YT; Zheng YY; Xie X
    Lipids Health Dis; 2020 Mar; 19(1):43. PubMed ID: 32178685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention.
    Reed GW; Masri A; Griffin BP; Kapadia SR; Ellis SG; Desai MY
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Coronary Microvascular Function Measured Immediately After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: An International Multicenter Study.
    Nishi T; Murai T; Ciccarelli G; Shah SV; Kobayashi Y; Derimay F; Waseda K; Moonen A; Hoshino M; Hirohata A; Yong ASC; Ng MKC; Amano T; Barbato E; Kakuta T; Fearon WF
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e007889. PubMed ID: 31525096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Zheng YY; Wu TT; Chen Y; Hou XG; Yang Y; Ma X; Ma YT; Zhang JY; Xie X
    Thromb Haemost; 2019 Jun; 119(6):1021-1030. PubMed ID: 30822808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Zhao Z; Wang J; Lei M; Li Y; Yang Y; An L; Sun X; Li C; Xue Z
    BMC Cardiovasc Disord; 2023 Mar; 23(1):168. PubMed ID: 36991321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease.
    Zheng YY; Wu TT; Guo QQ; Chen Y; Ma X; Ma YT; Zhang JY; Xie X
    Atherosclerosis; 2021 Jul; 328():1-10. PubMed ID: 34052667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of Renal Dysfunction at 1-Year Follow-Up on Clinical Outcomes After Percutaneous Coronary Intervention.
    Takahashi T; Watanabe T; Aono T; Otaki Y; Wanezaki M; Nishiyama S; Kutsuzawa D; Kato S; Tamura H; Arimoto T; Takahashi H; Watanabe M
    J Atheroscler Thromb; 2023 Jul; 30(7):786-794. PubMed ID: 36123047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Li J; Qiu H; Yan L; Guo T; Wang Y; Li Y; Zheng J; Tang Y; Xu B; Qiao S; Yang Y; Gao R
    J Atheroscler Thromb; 2021 Aug; 28(8):873-882. PubMed ID: 32908113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
    Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease.
    Di Gioia G; Soto Flores N; Franco D; Colaiori I; Sonck J; Gigante C; Kodeboina M; Bartunek J; Vanderheyden M; Van Praet F; Casselman F; Degriek I; Stockman B; Barbato E; Collet C; De Bruyne B
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009157. PubMed ID: 33040579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Kitahara H; Mori N; Saito Y; Nakayama T; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2019 Oct; 34(10):1595-1599. PubMed ID: 30968218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.
    Gong X; Zhou L; Ding X; Chen H; Li H
    BMC Cardiovasc Disord; 2021 Apr; 21(1):182. PubMed ID: 33858349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.
    Valle JA; McCoy LA; Maddox TM; Rumsfeld JS; Ho PM; Casserly IP; Nallamothu BK; Roe MT; Tsai TT; Messenger JC
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.